http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112972679-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2021-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112972679-B |
| titleOfInvention | A polypeptide-coupled boron carrier and its preparation method and pharmaceutical preparation |
| abstract | The invention discloses a boron-carrying agent, a preparation method and a pharmaceutical preparation thereof, wherein the boron-carrying agent comprises compound 1 N-4-carboxyphenylboronic acid amide-threo-benzene-phen-phenol-gan-gan-silk-essence- Gan-Lai-Jin-Aspart-Aspart-Benzene-Lay-Sue-Valu-Valu-Tyro-Cysteine, the molecular formula is C 114 H 158 BN 30 O 35 S 1 , the molecular weight is 2552.4, and it also includes Compound 2 N-4-Carboxyphenylboronic acid amide-es-lys-lys-lys-sing-sing-glutamyl-essence-arginine, and/or compound 3N-4-carboxyphenylboronic acid amide-methyl-propane-silk- M-Su-Gan-Gan-Glutyl-Glutyl-M-Glycine. The compound of the present invention can be used as a targeted boron neutron capture therapeutic drug for the treatment of brain glioma and head and neck tumors. |
| priorityDate | 2021-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.